top of page
FMC-21-01_GI_Alliance_WixBKG_v1.jpg
GI_Alliance_Logo_Horizontal.png

Advancing GI Patient Care 2021

Saturday, July 24, 2021
8:00 AM - 4:15 PM CDT

Thank you for joining us!
About

ABOUT

We are pleased to announce that Advancing GI Patient Care 2021 will take place on Saturday, July 24, 2021 at Live! by Loews – Arlington, Texas.

 

Advancing GI Patient Care 2021 will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders to approximately 300 GI Alliance healthcare providers virtually and in-person. It will feature an interactive format to enhance the educational impact. Internationally renowned hepatologists and gastroenterologists will lead the development of educational content and will serve as program faculty. The faculty will review state-of-the art developments in gastrointestinal (GI) disorders and chronic liver disease (CLD), including, but not limited to, gastroparesis (GP), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), iron deficiency anemia (IDA), hepatitis B (HBV), hepatitis C (HCV), hepatocellular carcinoma (HCC), hepatic encephalopathy (HE), cholestatic liver diseases, hepatorenal syndrome (HRS), exocrine pancreatic insufficiency (EPI), nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH).

 

The forum will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with CLD and GI disorders.

Agenda

Saturday, July 24, 2021*

All times reflect CDT

 

7:15 – 8:00 AM

Registration & Breakfast

8:00 – 8:10 AM                    

Welcome from Course Director

Timothy Ritter, MD (GI Alliance)

 

8:10 – 8:30 AM                     

Management of Rectal Cancer

Farshid Araghizadeh, MD (GI Alliance Southlake)

 

8:30 – 8:50 AM

Clinical Applications of Endoflip and Esoflip

Scott D. Pollack, MD (GI Alliance Metro New Orleans)

8:50 – 9:10 AM

Advances in Diagnostic and Therapeutic Endoscopy

Jayaprakash Sreenarasimhaiah, MD (GI Alliance Irving)

 

9:10 – 9:30 AM                     

Q&A / Panel Discussion

 

9:30 – 9:45 AM                     

Break

 

9:45 – 10:05 AM                  

Crohn’s Disease: Politics, Prednisone and Poop

Kimberly Persley, MD ​(GI Alliance/Presbyterian Hospital Dallas)

 

10:05 – 10:25 AM                

IBD Parenthood Pathway

Rajeev Jain, MD (GI Alliance/Presbyterian Hospital Dallas)

 

10:25 – 10:45 AM                 

Management of IBD Complications (incl. IDA)

Jonathan Casey Chapman, MD (GI Alliance)

 

10:45 – 11:05 AM                

Treat to Target and Emerging Therapies in IBD

Bincy Abraham, MD (Houston Methodist – Weill Cornell)

 

11:05 – 11:20 AM                 

Q&A / Panel Discussion

 

11:20 – 11:50 AM                 

Lunch Break 

11:50 AM – 12:50 PM                 

Lunch Product Theater Sponsored by Abbvie

What’s Next? Considering Case Studies to Inform Treatment Decisions for Patients with Crohn’s Disease (CD)

Jonathon Casey Chapman, MD and Brooke Hodnick, MPAS, PA-C

12:50 – 1:20 PM

Break

1:20 – 1:40 PM                   

Beyond Gut Instincts – Latest Advances in Diagnosis & Management of IBS, and Gut Microbiome Developments

Lawrence Schiller, MD (Baylor University Medical Center)

 

1:40 – 2:00 PM                       

Refractory IBS: Time to Consider Disaccharidase Deficiencies

Daksesh Patel, MD (GI Alliance Chicago)                     

 

2:00 – 2:15 PM                    

Q&A / Panel Discussion

 

2:15 – 2:30 PM                     

Break

 

2:30 – 2:50 PM                     

Management of Complications of Cirrhosis

Nayan Patel, DO, MPH (GI Alliance Arizona)

 

2:50 – 3:10 PM                    

Cholestatic Liver Diseases: Best Practices &
Emerging Therapies

Anil Seetharam, MD (GI Alliance Arizona)      

 

3:10 – 3:30 PM                    

Chronic Hepatitis B Screening and Treatment

Charles Phan, MD (GI Alliance Houston)     

 

3:30 – 3:50 PM                    

NAFLD/NASH: Current Management & Treatments on
the Horizon

Stephen Harrison, MD (Pinnacle Clinical Research)

 

3:50 – 4:05 PM                    

Q&A Panel Discussion

 

4:05 – 4:15 PM                     

Closing from Course Director

Timothy Ritter, MD (GI Alliance)

 

4:15 PM                                 

Adjourn

Earn up to
5.25
AMA PRA Category 1 Credits
Schedule
Loews Arlington_Patio.jpeg

VENUE

Live! by Loews - Arlington, Texas

1600 E Randol Mill Road

Arlington, TX 76011

VENUE
CONTACT

contact

Thanks for submitting!

Sponsorship Opportunities 

For details on sponsorship opportunities, please contact: 

Robert Taglienti

Director, Business Development

Focus Medical Communications

Tel: 862-219-8650

Email: rtaglienti@focusmeded.com

To learn more about the 2022 conference, please visit, https://www.advancinggipatientcare.org/

Accredited by:

Rehoboth_2021.png

This program is supported by an educational grant from
AbbVie, Janssen Biotech, Inc., Mallinckrodt Pharmaceuticals, Pfizer Inc., and Takeda Pharmaceuticals U.S.A., Inc.

bottom of page